Antonio Capaldi

Author PubWeight™ 13.10^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.	Blood	2008	2.68
2	Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.	Blood	2004	1.37
3	Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience.	Biol Blood Marrow Transplant	2009	1.19
4	Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers.	Int Immunol	2008	1.12
5	Complete resolution of life-threatening bleomycin-induced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin's lymphoma: hope for severe chemotherapy-induced toxicity?	J Clin Oncol	2011	0.96
6	Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD.	Blood	2006	0.92
7	Percutaneous vertebroplasty in multiple myeloma: prospective long-term follow-up in 106 consecutive patients.	Cardiovasc Intervent Radiol	2011	0.87
8	Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer: a pilot phase II study.	Am J Clin Oncol	2003	0.87
9	Expression of the c-ErbB-2/HER2 proto-oncogene in normal hematopoietic cells.	J Leukoc Biol	2003	0.86
10	A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer.	Oncology	2004	0.85
11	Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability.	Breast Cancer Res Treat	2003	0.82
12	Lentiviral transduction of primary myeloma cells with CD80 and CD154 generates antimyeloma effector T cells.	Hum Gene Ther	2005	0.77